SCHEMBL9131395

SCHEMBL9131395

CCCN(CCC)c1cnc2ccccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.50
▸ TRPV1 Q8NER1 3/20 0.46
▸ PDGFRB P09619 2/20 0.45
▸ PDGFRA P16234 2/20 0.45
▸ LMNA P02545 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ TLR8 Q9NR97 4/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ MET P08581 1/20 0.41
▸ BIRC5 O15392 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ MGAM O43451 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23028112 0.90 TRPV1 (0.48) CYP1A2TRPV1PDGFRBPDGFRALMNA
SCHEMBL1253866 0.76 CYP1A2 (0.59) CYP1A2PDGFRBPDGFRARAB9AALDH1A1
SCHEMBL13749462 0.74 TRPV1 (0.45) CYP1A2TRPV1PDGFRBPDGFRALMNA
Hydrochloric Acid SCHEMBL8326092 0.74 CYP1A2 (0.57) CYP1A2PDGFRBPDGFRARAB9AALDH1A1
SCHEMBL27941834 0.74 INSR (0.47) CYP1A2RAB9AMAPTKDM4E
SCHEMBL16483982 0.74 CYP1A2 (0.52) CYP1A2PDGFRBPDGFRALMNAPOLB
SCHEMBL12890436 0.74 CYP1A2 (0.52) CYP1A2PDGFRBPDGFRARAB9ATLR8
SCHEMBL14582925 0.74 PDE10A (0.44) LMNARAB9AALDH1A1MAPTHPGD
SCHEMBL14680365 0.74 CYP1A2 (0.55) CYP1A2PDGFRBPDGFRALMNAPOLB
SCHEMBL9288445 0.73 MAPT (0.40) CYP1A2TRPV1TLR8MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 — — US disclosed
Send feedback